151-165 of 949
Managing Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
Heart MattersManaging Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
Improving Lipid Management Through Equity-Focused Clinical Strategies
Heart MattersImproving Lipid Management Through Equity-Focused Clinical Strategies
Optimizing Cardiovascular Outcomes in Hyperlipidemia Through Risk-Based Care
Heart MattersOptimizing Cardiovascular Outcomes in Hyperlipidemia Through Risk-Based Care
PCSK9 Inhibitors and Statins: Meta-Analysis Highlights Benefit of Combination Therapy
Heart MattersPCSK9 Inhibitors and Statins: Meta-Analysis Highlights Benefit of Combination Therapy
Integrating Lipoprotein(a) Into Cardiovascular Risk Assessment
Heart MattersIntegrating Lipoprotein(a) Into Cardiovascular Risk Assessment
Triglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
Heart MattersTriglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
- advertisement
Retinal Vein Occlusion as a Predictor of Stroke
Eye on Ocular HealthRetinal Vein Occlusion as a Predictor of Stroke
Navigating Iron Deficiency Anemia: A Practical Guide for Gastroenterologists
GI InsightsNavigating Iron Deficiency Anemia: A Practical Guide for Gastroenterologists
Thomas DeLoughery, MD
Peter Buch, MD, FACG, AGAF, FACP
Managing Anticoagulants During Acute GI Bleeds: Guideline-Based Best Practices
GI InsightsManaging Anticoagulants During Acute GI Bleeds: Guideline-Based Best Practices
Peter Buch, MD, FACG, AGAF, FACP
Neena Abraham, MD, MS
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Heart MattersTimely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Kevin Alexander, MD
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
Heart MattersEquitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
Kevin Alexander, MD
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Heart MattersTranslating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
- advertisement
Staging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Heart MattersStaging the Benefit: Tafamidis Outcomes in ATTR-CM Depend on Timing
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
Heart MattersAnalyzing Outpatient Worsening Heart Failure in ATTR-CM
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Heart MattersCurrent and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Ahmad Masri, MD, MS
